Tech Times on MSN
Cell therapy maker Pluri takes 50% of ZEO to crack regenerative medicine's $400K cost floor
Regenerative medicine commercialization advanced October 26, 2026, as Pluri Inc. and ZEO ScientifiX announced a 50-50 equity ...
There are bad movies, there are movies that are so bad they’re good, and then there’s VelociPastor 2 , a movie so gloriously ...
OpenAI says its models proved the local smoothing conjecture in every dimension, resolving Kakeya and Stein, with a Lean ...
Meta Platforms, Inc. remains a Strong Buy as AI boosts ads and engagement. Click for this META earnings update and see if it ...
Two public presentations and a school board vote are scheduled for Tuesday that will affect three high schools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results